tiprankstipranks
Trending News
More News >
Moleculin Biotech (DE:MOL0)
FRANKFURT:MOL0
Germany Market

Moleculin Biotech (MOL0) Financial Statements

Compare
3 Followers

Moleculin Biotech Financial Overview

Moleculin Biotech's market cap is currently $9.51M. The company's EPS TTM is €2.2803842823; its P/E ratio is -1.17; Moleculin Biotech is scheduled to report earnings on March 19, 2026, and the estimated EPS forecast is €-1.50. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ -90.00K$ 0.00$ 0.00$ 0.00$ 0.00
Operating Income$ -25.10M$ -26.64M$ -29.63M$ -30.64M$ -22.97M
EBITDA$ -25.01M$ -26.52M$ -29.50M$ -30.51M$ -22.80M
Net Income$ -33.56M$ -21.76M$ -29.77M$ -29.02M$ -15.89M
Balance Sheet
Cash & Short-Term Investments$ 8.88M$ 4.28M$ 23.55M$ 43.15M$ 70.90M
Total Assets$ 22.13M$ 16.93M$ 38.22M$ 57.42M$ 84.09M
Total Debt$ 222.00K$ 478.00K$ 574.00K$ 451.00K$ 159.00K
Net Debt$ -8.66M$ -3.80M$ -22.98M$ -42.69M$ -70.74M
Total Liabilities$ 7.12M$ 10.95M$ 12.14M$ 5.23M$ 5.10M
Stockholders' Equity$ 15.01M$ 5.98M$ 26.07M$ 52.19M$ 78.99M
Cash Flow
Free Cash Flow$ -22.73M$ -23.88M$ -24.23M$ -27.71M$ -18.97M
Operating Cash Flow$ -22.73M$ -23.86M$ -24.10M$ -27.64M$ -18.95M
Investing Cash Flow$ 0.00$ -13.00K$ -124.00K$ -67.00K$ -19.00K
Financing Cash Flow$ 27.28M$ 4.63M$ 4.65M$ -23.00K$ 74.72M
Currency in USD

Moleculin Biotech Earnings and Revenue History

Moleculin Biotech Debt to Assets

Moleculin Biotech Cash Flow

Moleculin Biotech Forecast EPS vs Actual EPS